Bellevue Group’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,500
| Closed | -$97.5K | – | 151 |
|
|
2024
Q4 | $97.5K | Hold |
41,500
| – | – | ﹤0.01% | 155 |
|
|
2024
Q3 | $151K | Buy |
41,500
+9,000
| +28% | +$32.7K | ﹤0.01% | 151 |
|
|
2024
Q2 | $113K | Hold |
32,500
| – | – | ﹤0.01% | 156 |
|
|
2024
Q1 | $207K | Sell |
32,500
-17,500
| -35% | -$112K | ﹤0.01% | 154 |
|
|
2023
Q4 | $322K | Buy |
+50,000
| New | +$322K | ﹤0.01% | 147 |
|
|
2020
Q1 | – | Sell |
-62,200
| Closed | -$821K | – | 217 |
|
|
2019
Q4 | $821K | Buy |
62,200
+27,600
| +80% | +$364K | 0.01% | 152 |
|
|
2019
Q3 | $430K | Buy |
34,600
+600
| +2% | +$7.46K | 0.01% | 186 |
|
|
2019
Q2 | $547K | Buy |
+34,000
| New | +$547K | 0.01% | 144 |
|